Comunicats de premsa

09 d’oct. 2014

Synthon Announces Filing of Glatiramer Acetate 40 mg/mL ANDA Containing a Paragraph IV Certification

read more
15 d’abr. 2014

Synthon obtains European approvals for sevelamer

read more
27 de març 2014

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

read more
     Share this page